{"filing":{"accession":"0001106578-26-000132","url":"/filing/0001106578-26-000132","form_type":"4","issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_name_source":null,"issuer_ticker":"UTHR","issuer_url":"/issuer/0001082554","period_of_report":"2026-08-31","filed_date":"2026-09-01","acceptance_dt":"2026-09-01T16:33:53+00:00","acceptance_label":"2026-09-01 16:33 UTC","ingested_at":"2026-09-02T05:26:30.437746+00:00","ingested_label":"2026-09-02 05:26 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000132-index.htm","day_url":"/filings/2026-09-01"},"owners":[{"owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","url":"/insider/0001106578","anchor":"owner-0001106578","role":"Director, Officer (Chairperson & CEO)","officer_title":"Chairperson & CEO","is_director":true,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001106578-26-000132#owner-0001106578"}],"line_owners":[{"owner_name":"ROTHBLATT MARTINE A","role":"Director, Officer (Chairperson & CEO)"}],"transactions":[{"id":9303422,"accession":"0001106578-26-000132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001106578-26-000132","line_url":"/filing/0001106578-26-000132#line-1","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":599.0,"shares_display":"599","price_per_share":507.8437,"price_display":"507.84","price_state":"stated","total_value":304198.3763,"total_display":"304,198.38","total_whole":"304,198","shares_owned_after":333344.0,"shares_owned_after_display":"333,344","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-31","filed_date":"2026-09-01","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9303421,"accession":"0001106578-26-000132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001106578-26-000132","line_url":"/filing/0001106578-26-000132#line-2","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":794.0,"shares_display":"794","price_per_share":508.9199,"price_display":"508.92","price_state":"stated","total_value":404082.4006,"total_display":"404,082.40","total_whole":"404,082","shares_owned_after":332550.0,"shares_owned_after_display":"332,550","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-31","filed_date":"2026-09-01","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9303420,"accession":"0001106578-26-000132","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001106578-26-000132","line_url":"/filing/0001106578-26-000132#line-3","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":810.0,"shares_display":"810","price_per_share":509.8359,"price_display":"509.84","price_state":"stated","total_value":412967.079,"total_display":"412,967.08","total_whole":"412,967","shares_owned_after":331740.0,"shares_owned_after_display":"331,740","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-31","filed_date":"2026-09-01","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9303419,"accession":"0001106578-26-000132","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001106578-26-000132","line_url":"/filing/0001106578-26-000132#line-4","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4217.0,"shares_display":"4,217","price_per_share":510.9315,"price_display":"510.93","price_state":"stated","total_value":2154598.1355,"total_display":"2,154,598.14","total_whole":"2,154,598","shares_owned_after":327523.0,"shares_owned_after_display":"327,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-31","filed_date":"2026-09-01","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9303418,"accession":"0001106578-26-000132","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001106578-26-000132","line_url":"/filing/0001106578-26-000132#line-5","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":511.7505,"price_display":"511.75","price_state":"stated","total_value":818800.8,"total_display":"818,800.80","total_whole":"818,801","shares_owned_after":325923.0,"shares_owned_after_display":"325,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-31","filed_date":"2026-09-01","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9303417,"accession":"0001106578-26-000132","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001106578-26-000132","line_url":"/filing/0001106578-26-000132#line-6","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":678.0,"shares_display":"678","price_per_share":513.5019,"price_display":"513.50","price_state":"stated","total_value":348154.2882,"total_display":"348,154.29","total_whole":"348,154","shares_owned_after":325245.0,"shares_owned_after_display":"325,245","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-31","filed_date":"2026-09-01","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9303416,"accession":"0001106578-26-000132","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001106578-26-000132","line_url":"/filing/0001106578-26-000132#line-7","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":762.0,"shares_display":"762","price_per_share":514.3214,"price_display":"514.32","price_state":"stated","total_value":391912.9068,"total_display":"391,912.91","total_whole":"391,913","shares_owned_after":324483.0,"shares_owned_after_display":"324,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-31","filed_date":"2026-09-01","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9303415,"accession":"0001106578-26-000132","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001106578-26-000132","line_url":"/filing/0001106578-26-000132#line-8","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40.0,"shares_display":"40","price_per_share":514.96,"price_display":"514.96","price_state":"stated","total_value":20598.4,"total_display":"20,598.40","total_whole":"20,598","shares_owned_after":324443.0,"shares_owned_after_display":"324,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-31","filed_date":"2026-09-01","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":8,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-09-02T05:26:30.437746+00:00","retrieved_label":"2026-09-02 05:26 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000132-index.htm","accepted_at":"2026-09-01T16:33:53+00:00","accepted_label":"2026-09-01 16:33 UTC"},"related":[],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001106578-26-000132","retrieved_at":"2026-09-02T08:13:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-09-01","last_ingest":"2026-09-02T05:26:30.437746+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}